v3.25.4
Condensed Interim Consolidated Statements of Stockholders’ (Deficiency) Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance beginning at Oct. 31, 2024 $ 2,541,515 $ 141,723,305 $ (138,814,271) $ 92,248 $ 5,542,797
Balance beginning (in Shares) at Oct. 31, 2024 47,365,652        
- Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12) 14,721 14,721
Net loss (102,386) (102,386)
Balance ending at Jan. 31, 2025 $ 2,541,515 141,738,026 (138,916,657) 92,248 5,455,132
Balance ending (in Shares) at Jan. 31, 2025 47,365,652        
Balance beginning at Oct. 31, 2025 $ 2,560,788 142,358,630 (151,917,277) 92,248 $ (6,905,611)
Balance beginning (in Shares) at Oct. 31, 2025 49,292,882       49,292,882
- Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12) 4,293 $ 4,293
Net loss (119,693) (119,693)
Balance ending at Jan. 31, 2026 $ 2,560,788 $ 142,362,923 $ (152,036,970) $ 92,248 $ (7,021,011)
Balance ending (in Shares) at Jan. 31, 2026 49,292,882       49,292,882